Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma
LPAR6 is the most recently determined G-protein-coupled receptor of the lysophosphatidic acid receptor, and very few of studies have demonstrated the performance of LPAR6 in cancers. Moreover, the relationship of LPAR6 to the potential of prognosis and tumor infiltration immune cells in different ty...
Saved in:
Main Authors: | Jian He, Rui Gao, Mei Meng, Miao Yu, Chengrong Liu, Jingquan Li, Yizhi Song, Hui Wang |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/fc06d96d8d3e47ae9e4c9e9316b94409 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
by: Guojun Lu, et al.
Published: (2021) -
Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
by: Zhang Zhihui, et al.
Published: (2021) -
LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma
by: Lin Z, et al.
Published: (2021) -
LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
by: Xin Jin, et al.
Published: (2021) -
Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
by: Maja Šutić, et al.
Published: (2021)